Evidence map›Paper›PMID 39765662›Full record

ArticleBiology2024

Vimentin Intermediate Filaments Maintain Membrane Potential of Mitochondria in Growing Neurites.

Alexander A Dayal, Olga I Parfenteva, Huiying Wang, Blen Amare Gebreselase, Fatima K Gyoeva, Irina B Alieva, Alexander A Minin

Abstract read
In one paragraph

Article in Biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander A DayalInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.
Olga I ParfentevaInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.ORCID 0000-0001-7895-6887
Huiying WangInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.
Blen Amare GebreselaseInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.
Fatima K GyoevaInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.
Irina B AlievaInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.ORCID 0000-0002-5726-4889
Alexander A MininInstitute of Protein Research, Russian Academy of Sciences, 119334 Moscow, Russia.

Funding

Russian Science Foundation 23-74-00036
6 · The paper itself

Abstract

Neural precursor cells contain two types of intermediate filaments (IFs): neurofilaments consisting of three IV type proteins and vimentin belonging to the type III IF proteins that disappear at the later stages of differentiation. The involvement of vimentin in neurogenesis was demonstrated earlier; however, the role of its temporary expression in neurons is not clear. We showed that the vimentin IFs that interacted with mitochondria maintained their membrane potential at the appropriate level, and thus, ensured their proper function. We examined the dependence of the mitochondrial membrane potential on the expression of vimentin in a CAD catecholaminergic neuronal cell line that was actively dividing in full culture media but stopped growing and started developing neurites when the serum was removed. Using the CRISPR Cas9 system to knock out the vimentin gene in these cells, we investigated the impact of this on the mitochondrial membrane potential. Our data show that the deletion of the vimentin IFs led to a decrease in the level of the mitochondrial potential. When the vimentin network in these cells was reconstituted by transfection with a plasmid that encoded human protein, the level of the potential was restored. Interestingly, mutated vimentin with a disrupted mitochondria-binding site had no such effect. Our data point to vimentin as a possible target in some neurological pathologies.

Indexed as

intermediate filament (IF)mitochondriamitochondrial membrane potentialvimentin

Identifiers

PMID39765662
PMCPMC11726714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.